Areteia Therapeutics introduces dexpramipexole, a novel oral drug in Phase 3 trials for asthma and COPD, aiming for approval ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

USE ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson’s disease (PD). It is not known if ONAPGO is safe and effective in children.

Hanging the washing out to dry in the garden has been a rare sight these last few months, with winter storms bringing freezing temperatures and 100mph ...

In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a ...

Looking for the name of Marcel Proust on search engines, it seems that the centenary of his death (1922) has gone unnoticed by medical doctors. Several essays on his illness have already been ...